Biochemical assessment of bone disease in multiple myeloma

This publication has 17 references indexed in Scilit:

• The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma
  British Journal of Haematology, 1983
• Plasma hydroxyproline in uremia: Relationships with histologic and biochemical indices of bone turnover
  Metabolic Bone Disease and Related Research, 1983
• Quantitative histology of myeloma‐induced bone changes
  British Journal of Haematology, 1982
• Evaluation of Serial Bone X‐ray Examination in Multiple Myeloma
  Acta Medica Scandinavica, 1982
• Clinical evaluation of myeloma osteoclastic bone lesions: II. Induced hypocalcemia test using salmon calcitonin
  Metabolic Bone Disease and Related Research, 1982
• The postabsorptive urinary hydroxyproline (Spot-HYPRO) in patients with multiple myeloma
  Cancer, 1981
• Relation of Osteoclast Activating Factor Production to Extent of Bone Disease in Multiple Myeloma
  British Journal of Haematology, 1981
• Combination therapy for multiple myeloma
  Cancer, 1977
• A modified inactivation - inhibition method for determining the serum activity of alkaline phosphatase isoenzymes
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1976
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
  Cancer, 1975